Cytovance Biologics - Ownership and Business Overview

Life ScienceCompany

Cytovance Biologics Ownership

Who owns Cytovance Biologics?

Cytovance Biologics is owned by Shenzhen Hepalink Pharmaceutical Group. It was acquired on August 24, 2015.

Was Cytovance Biologics formerly PE-backed?

Yes. Cytovance Biologics was formerly owned by 2 private investors.

Cytovance Biologics Business Overview

Where is Cytovance Biologics headquartered?

Cytovance Biologics is headquartered in Oklahoma City, Oklahoma.

What sector is Cytovance Biologics in?

Cytovance Biologics is a life science company.

When was Cytovance Biologics founded?

Cytovance Biologics was founded in 2003.

Life Science M&A Summary in 2015

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.

Join Mergr to view all 293 acquisitions of life science companies in 2015, including 32 acquisitions by private equity firms, and 261 by strategics.

Cytovance Biologics, Inc.

800 Research Parkway, Suite 200,
Oklahoma City, Oklahoma 73104
United States,
(405) 319-8310
www.cytovance.com

Cytovance is a contract manufacturing organization of mammalian and microbial biologics. The company works with biotechnology and pharmaceutical companies in the development and manufacturing of proteins, antibodies, and cell-based therapeutic products. Cytovance supports its customers from clinical development to commercial launch in domestic and international markets.


 Subscribe to unlock this and 201,888
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.